Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salesforce, Inc. Director's Dealing 2024

Feb 21, 2024

29776_dirs_2024-02-21_d3dc9f0b-7915-493a-8f5c-621aa212abbd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Salesforce, Inc. (CRM)
CIK: 0001108524
Period of Report: 2024-02-20

Reporting Person: Tallapragada Srinivas (Pres/Chief Engineering Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-20 Common Stock M 10000 $154.14 Acquired 70416 Direct
2024-02-20 Common Stock S 2142 $285.2356 Disposed 68274 Direct
2024-02-20 Common Stock S 2996 $286.2739 Disposed 65278 Direct
2024-02-20 Common Stock S 500 $287.404 Disposed 64778 Direct
2024-02-20 Common Stock S 1000 $288.738 Disposed 63778 Direct
2024-02-20 Common Stock S 3109 $289.6048 Disposed 60669 Direct
2024-02-20 Common Stock S 253 $290.5828 Disposed 60416 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-20 Non-qualified Stock Option (Right to Buy) $154.14 M 10000 Disposed 2027-04-22 Common Stock (10000) Direct

Footnotes

F1: As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2023.

F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $284.6800 to $285.5900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $285.8200 to $286.7800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F4: Weighted average price. These shares were sold in multiple transactions at prices ranging from $287.2600 to $287.6000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F5: Weighted average price. These shares were sold in multiple transactions at prices ranging from $288.2900 to $289.1200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F6: Weighted average price. These shares were sold in multiple transactions at prices ranging from $289.4300 to $290.3600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F7: Weighted average price. These shares were sold in multiple transactions at prices ranging from $290.4800 to $290.6600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F8: Option vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.